https://www.sfdrmg.org/wiki/index.php?action=history&feed=atom&title=Discussion%3AHTA 2026-06-04T15:08:34Z Historique des révisions pour cette page sur le wiki MediaWiki 1.37.1 https://www.sfdrmg.org/wiki/index.php?title=Discussion:HTA&diff=5188&oldid=prev 2013-03-24T14:02:22Z

<p><span dir="auto"><span class="autocomment">Que faire en cas de prescription d’un IEC ou d’un ARA 2 ? : </span> nouvelle section</span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="fr"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 24 mars 2013 à 16:02</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l10">Ligne 10 :</td> <td colspan="2" class="diff-lineno">Ligne 10 :</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Qualité de la preuve: accord professionnel </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Qualité de la preuve: accord professionnel </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Source: National Institute for Health and Clinical Excellence (NICE) 2011. Hypertension: clinical management of primary hypertension in adults.</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Source: National Institute for Health and Clinical Excellence (NICE) 2011. Hypertension: clinical management of primary hypertension in adults.</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Que faire en cas de prescription d’un IEC ou d’un ARA 2 ? ==</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Il n'est pas recommandé d'associer un IEC et un ARA 2.</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Qualité de la preuve: grade A</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Source: Makani H ,Bangalore S ,Desouza KA ,Shah A ,Messerli FH. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ 2013;346:f360</ins></div></td></tr> </table>

Gérard Bergua https://www.sfdrmg.org/wiki/index.php?title=Discussion:HTA&diff=5187&oldid=prev 2013-03-24T12:54:06Z

<p>Page créée avec « HTA 3 Traitement 3.4 Quelles sont les mesures non médicamenteuses à préconiser chez le patient hypertendu ? • Une supplémentation en calcium, en magnésium ou en p... »</p> <p><b>Nouvelle page</b></p><div>HTA<br /> <br /> 3 Traitement<br /> <br /> 3.4 Quelles sont les mesures non médicamenteuses à préconiser chez le patient hypertendu ?<br /> <br /> â€Â¢ Une supplémentation en calcium, en magnésium ou en potassium n’est pas recommandée<br /> â€Â¢ Les techniques de relaxation peuvent abaisser la pression artérielle mais elle ne sont pas recommandées en routine de soins primaires<br /> <br /> Qualité de la preuve: accord professionnel <br /> Source: National Institute for Health and Clinical Excellence (NICE) 2011. Hypertension: clinical management of primary hypertension in adults.</div>

Gérard Bergua